Quantitatively determined survivin expression levels are of prognostic value in human gliomas

Journal of Clinical Oncology

Volumn 20, Issue 4, 2002, Pages 1063-1068

  Chakravarti, Arnab ^a   Noll, Elizabeth ^a   Black, Peter McL ^a   Finkelstein, Daniel F ^a   Finkelstein, Dianne M ^a   Dyson, Nicholas J ^a   Loeffler, Jay S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CASPASE 3; SURVIVIN;

ADULT; APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; EPENDYMOMA; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; WESTERN BLOTTING;

ADULT; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHROMOSOMAL PROTEINS, NON-HISTONE; CYSTEINE PROTEINASE INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037083317     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.4.1063     Document Type: Article

References (27)

1. The conditional probability of survival of patients with primary brain tumors: Surveillance, Epidemiology, and End Results (SEER) data
2. Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant gliomas after surgery
3. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
4. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
5. Alteration of lp and 19q as predictors of survival in oligodendrogliomas
6. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22,q32)
7. Proliferation, cell cycle and apoptosis in cancer
8. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
9. Prognostic significance of survivin expression in diffuse large B-cell lymphomas
10. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
11. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting
12. Survivin as a radioresistance factor in pancreatic cancer
13. Inhibition of melanoma tumor growth in vivo by survivin targeting
14. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
15. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer
16. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas
17. A novel ani-apoptosis gene: Re-expression of survivin messenger RNA as a prognostic marker in non-small cell lung cancers
18. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy
19. Urine detection of survivin and diagnosis of bladder cancer
20. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas
21. Malignant glioma: Genetics and biology of a grave matter
22. Protooncogene bcl-2 gene transfer abrogates Fas/APO-I antibody-mediated apoptosis and confers resistance to chemotherapeutic drugs and therapeutic irradiation
23. Relative level of expression of bax and bcl-xl determines the cellular fate of apoptosis/necrosis induced by the overexpression of bax
24. IAP family proteins-suppressors of apoptosis
25. Analysis of human transcriptomes
26. INK4A and cdk2/cyclin E complex activation
27. ARF in 105 human primary gliomas